TY - JOUR
T1 - The role of FDG-PET/CT imaging after radiation therapy
AU - Grigsby, Perry W.
PY - 2007/10
Y1 - 2007/10
N2 - FDG-PET/CT is both sensitive and specific for the detection of persistent cervical cancer in the immediate posttherapy setting (3 months) and in the long-term follow-up of these patients. The value in posttherapy surveillance is in the detection of asymptomatic recurrent disease than can successfully be salvaged. Based on time-to-recurrence data, it is recommended that patients undergo routine surveillance including a history, physical examination, and clinically indicated imaging studies. Routine FDG-PET/CT should be performed 3 months posttherapy, every 6 months for 3 years, every year for two additional years, and then as clinically indicated.
AB - FDG-PET/CT is both sensitive and specific for the detection of persistent cervical cancer in the immediate posttherapy setting (3 months) and in the long-term follow-up of these patients. The value in posttherapy surveillance is in the detection of asymptomatic recurrent disease than can successfully be salvaged. Based on time-to-recurrence data, it is recommended that patients undergo routine surveillance including a history, physical examination, and clinically indicated imaging studies. Routine FDG-PET/CT should be performed 3 months posttherapy, every 6 months for 3 years, every year for two additional years, and then as clinically indicated.
UR - http://www.scopus.com/inward/record.url?scp=34748821924&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2007.07.034
DO - 10.1016/j.ygyno.2007.07.034
M3 - Article
C2 - 17727930
AN - SCOPUS:34748821924
SN - 0090-8258
VL - 107
SP - S27-S29
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 1 SUPPL.
ER -